Trial Profile
A prospective study evaluated the efficacy of Azelastine/fluticasone-propionate (Dymista) versus prior treatments in patients with rhinitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Azelastine/fluticasone-propionate (Primary)
- Indications Perennial allergic rhinitis; Rhinitis; Seasonal allergic rhinitis
- Focus Therapeutic Use
- 23 Mar 2016 New trial record